spacer
home > pmps > summer 2019 > why automate?
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Why Automate?

There are many answers to the question 'why automate?', but the bottom line is: if you don’t, you will be left behind. Automation in the pharmaceutical industry affects costs, regulatory compliance, and productivity, so why do we need it?

Data, reproducibility, compliance, and, most importantly, reduction of human error. Can a machine make an error? Of course, it’s called a malfunction. Usually, it is the human who programmed the machine that caused it, so maintenance teams can help provide technical support to make sure the automated process is programmed correctly.

Once the system is set, there are fewer chances for deviation. Automation also provides an opportunity for round-the-clock work because machines do not need to take a break. The benefits of back-up cloud data and encryptions also provide secure systems that can be implemented globally without the need to retrain or reprogram your operations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer

spacer
Randice Altschul
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health Unveils its full Conference Line-up for SCOPE 2020

PHILADELPHIA, PA – February 11, 2020: The SCOPE Summit for Clinical Operations Executives annually convenes innovative thought leaders from across the life sciences industry to share ideas, challenges and best practices that will help drive change and improve patient centricity throughout the coming year and beyond. Subject matter experts from Signant Health will host and participate in key discussions on the importance of eConsent and patient engagement, the impact of data analytics on endpoint quality, and how to integrate sensors and wearables into eCOA trials as part of the patient journey through clinical research.
More info >>

White Papers

Device Develop for Combo Products

Phillips-Medisize

Combination products are defined as therapeutics combining two or more products (drug/device, biologics/device, biologics/drugs or drug/device/biologics), regulated and sold as a single unit. As these pharmaceutical and biological therapies and treatments have evolved, so has the need to develop appropriate delivery mechanisms for these applications. When developing a combination product, there are many things that need to be considered – the critical relationships between device development and the pharmaceutical or biologic, early establishment of regulatory and clinical strategies, understanding ‘user’ needs, determining product requirements, as well as, device manufacturing variation.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement